Jianxing

Survival outcomes Associated with Various Resistance Mechanisms of Osimertinib in Chinese Advanced Non-Small Cell Lung Cancer Patients

P. Xing, Junling Li, X. Hao, 2020, Journal of Cancer Research and Therapeutic Oncology.

clinical characterization of ERBB 2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in chinese lung cancer patients

Yong, Chengzhi, Zhe-feng Liu, 2018 .